[image 05206] RIKEN AIPの医学人工知能講演会（11/13 ハイブリッド開催）

[Lin Gu]

image-ml の皆様，

いつもお世話になっております。RIKEN AIPの谷と申します。

Case Western Reserve UniversityのLi Shuo 先生に，11/13（月）
13:00よりセミナーをしていただくことになりました．

直前の案内で恐縮ですが，以下のリンク
から皆さまぜひご登録をお願いいたします．



日時 ： 2023年11月13日（月）13:00～14:00（講演45分、質疑応答15分）

会場 ：東京大学駒場キャンパス２（ハイブリッド開催）

参加申込：下記URL先よりお申し込みください。
web申込先： https://c5dc59ed978213830355fc8978.doorkeeper.jp/events/165590

題目： AI to eliminate chemical contrast agent in imaging

概要：Chemical contrast agent-enhanced imaging plays a critical role in clinical diagnostic imaging. Recently there has been an increasing concern regarding the chemical contrast agent used in the clinic. In this talk, Dr. Li will share his ground-breaking AI contrast-enhanced imaging, which develops state-of-the-art machine-learning techniques to eliminate the need for chemical contrast agents.

Speaker bio:
Dr. Li is a global leader conducting multi-disciplinary research to enable artificial intelligence (AI) in clinical imaging. He is an associate professor at Case Western Reserve University. Before that, he was an associate professor in the Western University and a scientist at the Lawson Health Research Institute. He was a scientist at GE Healthcare (2006-2015). He is a committee member in multiple highly influential conferences and societies. He is most notable for serving on the prestigious board of directors in the MICCAI society (2015-2024), where he is also the general chair for the MICCAI 2022 conference, which is the most influential AI-in-imaging conference. He has over 200 publications, acted as the editor for six Springer books, and serves as an associate editor for several prestigious journals in the field. Throughout his career, he has received several awards from GE, various institutes, and international organizations.


よろしくお願いいたします。

谷　林



----------------------------------------------
Lin GU, Ph.D (谷 林)
RIKEN AIP
Research Scientist
https://scholar.google.com/citations?user=gIEZe5IAAAAJ&hl=en
理化学研究所　革新知能統合研究センター(AIP)
医用機械知能チーム　研究員
----------------------------------------------